Lepromatous leprosy and reversal reaction in a Micronesian immigrant von Ross, Rustin R., Herron, Mark D., Florell, Scott R.

Volltext

Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations von Padhani, Anwar R., Liu, Guoying, Mu-Koh, Dow, Chenevert, Thomas L., Thoeny, Harriet C., Takahara, Taro, Dzik-Jurasz, Andrew, Ross, Brian D., Van Cauteren, Marc, Collins, David, Hammoud, Dima A., Rustin, Gordon J.S., Taouli, Bachir, Choyke, Peter L.

Volltext

Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance Imaging von GALBRAITH, Susan M, MAXWELL, Ross J, LODGE, Martin A, TOZER, Gillian M, WILSON, John, TAYLOR, N. Jane, STIRLING, J. James, SENA, Luiza, PADHANI, Anwar R, RUSTIN, Gordon J. S

Volltext

Phase I Clinical and Pharmacokinetic Evaluation of the Vascular-Disrupting Agent OXi4503 in Patients with Advanced Solid Tumors von PATTERSON, Dan M, ZWEIFEL, Martin, CHAPLIN, Dai J, PADHANI, Anwar R, RUSTIN, Gordon J. S, MIDDLETON, Mark R, PRICE, Patricia M, FOLKES, Lisa K, STRATFORD, Michael R. L, ROSS, Phil, HALFORD, Sarah, PETERS, Jane, BALKISSOON, Jai

Volltext

Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial von Cummings, J, Zweifel, M, Smith, N, Ross, P, Peters, J, Rustin, G, Price, P, Middleton, M R, Ward, T, Dive, C

Volltext

Epidermotropic metastasis from vulvar squamous cell carcinoma: A rare cutaneous manifestation von Wang, Annie R., ScB, O'Brien, Meghan, MD, Ross, Rustin, MD, Long, Thomas, MD, Robinson-Bostom, Leslie, MD

Volltext

Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI von Maxwell, Ross J., Wilson, John, Prise, Vivien E., Vojnovic, Borivoj, Rustin, Gordon J., Lodge, Martin A., Tozer, Gillian M.

Volltext

A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer von Gore, M, Oza, A, Rustin, G, Malfetano, J, Calvert, H, Clarke-Pearson, D, Carmichael, J, Ross, G, Beckman, R.A, Fields, S.Z

Volltext

Phase I pharmacokinetic and pharmacodynamic evaluation of the vascular disrupting agent OXi4503 in patients with advanced solid tumors von Zweifel, M., Patterson, D. M., Padhani, A. R., Middleton, M. R., Price, P., Stratford, M. R., Ross, P., Halford, S., Goldberg, Z., Rustin, G. J.

Volltext

Topotecan given as a 21-day infusion in the treatment of advanced ovarian cancer von Gore, M, Rustin, G, Schüller, J, Lane, S R, Hearn, S, Beckman, R A, Ross, G

Volltext